Increased expression of ADAM33 and ADAM8 with disease progression in asthma
Increased expression of ADAM33 and ADAM8 with disease progression in asthma
复制标题
DOI:
10.1016/j.jaci.2006.12.665
复制
发表时间:
2007-04-01
影响因子:
14.2
通讯作者:
Hamid, Qutayba
中科院分区:
文献类型:
--
作者:
Foley, Susan C.;Mogas, Andrea K.;Hamid, Qutayba
Background: ADAM33, a disintegrin and metalloproteinase 33 gene, has been identified as a risk factor for asthma and bronchial hyperresponsiveness and has been postulated as a gene for airway remodeling. ADAM8 is strongly induced by allergens and T(H)2 cytokines; in the lung in experimental asthma.Objectives: To assess the importance of these genes in asthma pathogenesis and to investigate whether expression relates to disease severity or deterioration in lung function, we measured the mRNA and protein expression of both genes in bronchial biopsies of subjects with asthma and control subjects.Methods: RNA was extracted from frozen endobronchial biopsies of mild. moderate, and severe adults with asthma and controls. Subjects with moderate and severe asthma were taking corticosteroids. The mRNA transcript of both genes was measured by real time RT-PCR using specific primers. Protein expression was examined by immunohistochemistry on paraffin sections.Results: ADAM33 mRNA expression was significantly higher in both moderate and severe asthma compared with mild asthma (P